Advertisement

Hadronentherapie

  • D. Schulz-Ertner
  • J. Debus
Chapter

Zusammenfassung

Parallel zu den Entwicklungen in der Photonentherapie wurde in den letzten Jahrzehnten auch die Teilchentherapie mit Protonen und schwereren Ionen wie Kohlenstoffionen weiterentwickelt.

Literatur

  1. Akakura K, Tsujii H, Morita S et al. (2004) Phase I/II clinical trials for carbon ion therapy for prostate cancer. Prostate 15, 61(1):103Google Scholar
  2. Ares C, Hug EB, Lomax AJ et al. (2009) Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base : first long-term report. Int J Radiat Oncol Biol Phys 75(4):1111–1118PubMedGoogle Scholar
  3. Avery CM, Moody AB, McKinna FE et al. (2000) Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 29(4):277–279PubMedGoogle Scholar
  4. Batterman JJ, Breur K, Hart GA et al. (1981) Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60-gamma rays. Eur J Cancer 17:539–548Google Scholar
  5. Benk V, Liebsch NJ, Munzenrider JE et al. (1995) Base of skull and cervical spine chordoma in children treated by highdose irradiation. Int J Radiat Oncol Biol Phys 31:577–581PubMedGoogle Scholar
  6. Bert C, Gemmel A, Saito N, Rietzel E (2009) Gated irradiation with scanned particle beams. Int J Radiat Oncol Biol Phys 73(4):1270–1275PubMedGoogle Scholar
  7. Boskos C, Feuvret L, Noel G et al (2009) Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75(2):399–406PubMedGoogle Scholar
  8. Breteau N, Wachter T, Kerdraon R et al. (2000) Use of fast neutrons in the treatment of the saliary glands: rationale, review of the literature and experience in Orleans. Cancer Radiother 4(3):181–190PubMedGoogle Scholar
  9. Buchholz TA, Laramore GE, Griffin BR et al. (1992) The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 69(11):2779–2788PubMedGoogle Scholar
  10. Bush DA et al. (2002) Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 50(2):270–275PubMedGoogle Scholar
  11. Bush DA, Slater JD, Bonnet R et al. (1999) Proton-beam radiotherapy for early-stage lung cancer. Chest 116(5):1313–1319PubMedGoogle Scholar
  12. Bush DA, Slater JD, Shin BB, et al. (2004) Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126(4):1198–1203PubMedGoogle Scholar
  13. Cahlon O, Zelefsky MJ, Shippy A et al. (2008) Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71(2):330–337PubMedGoogle Scholar
  14. Castro JR, Char DH, Petti PI et al. (1997) 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys39:989–996PubMedGoogle Scholar
  15. Castro JR, Linstadt DE, Bahary JP et al. (1994) Experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys 29:647–655PubMedGoogle Scholar
  16. Catterall M, Bewley DK (1977) Second report on results of a randomized clinical trial of fast neutrons compared with X or gamma rays in the treatment of advanced tumous of the head and neck. Br Med J 1:1642PubMedGoogle Scholar
  17. Catton C, O’Sullivan B, Bell R et al. (1996) Chordoma: Longterm follow-up after radical photon irradiation. Radiother Oncol 41:67–72PubMedGoogle Scholar
  18. Char DH, Quivey JM, Castro JR et al. (1993) Helium ions versus ioding 125 brachytherapy in the management of uveal melanomna. A prospective, randomized, dynamically balanced trial. Ophthal 100(10):1547–1554Google Scholar
  19. Chiba T, Tokuuye K, Matsuzaki Y et al. (2005) Proton beam therapy for hepatocellular carcinoma : a retrospective review of 162 patients. Clin Cancer Res 11(10):3799–3805PubMedGoogle Scholar
  20. Combs SE, Nikoghosyan A, Jaekel O, et al (2009) Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer 115(6):1348–1355PubMedGoogle Scholar
  21. Combs SE, Hartmann C, Nikoghosyan A et al. (2010) Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol 95:54–59PubMedGoogle Scholar
  22. Debus J et al. (2000 a) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. JCO 19(15):3547–3553Google Scholar
  23. Debus J, Schulz-Ertner D, Schad L et al. (2000 b) Stereotactic fractionated radiation therapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591–596PubMedGoogle Scholar
  24. DeLaney TF, Liebsch NJ, Pedlow FX et al. (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74(3):732–739PubMedGoogle Scholar
  25. Desjardins L, Levy C, D’Hermies F et al. (1997) Initial results of proton therapy in chordoidal melanoma at the d’Orsay Center for Proton Therapy. Cancer Radiother 1(3):222–226PubMedGoogle Scholar
  26. Douglas JG, Laramore GE, Austin-Seymour M et al. (2000) Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys 46(3):551–557PubMedGoogle Scholar
  27. Duncan W, Orr JA, Arnott SJ et al. (1987) Neutron therapy for malignant tumours of the salivary glands. A report of the Edinburgh experience. Radiother Oncol 8(2):97–104PubMedGoogle Scholar
  28. Egger E, Zografos L, Munkel G et al. (1997) Results of proton radiotherapy for uveal melanomas. Front Radiat Ther Oncol 30:111–122PubMedGoogle Scholar
  29. Elsässer T, Scholz M (2006) Improvement of the local effect model (LEM) – implications of clustered DNA damage. Radiat Prot Dosimetry 122(1-4):475–477.PubMedGoogle Scholar
  30. Fitzek MM et al. (1999) Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1(2):251–260Google Scholar
  31. Ford EC, Mageras GS, Yorke E et al. (2002) Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol 52(2):522–531Google Scholar
  32. Forman JD, Porter AT (1997) The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate. Semin Urol Oncol 15:239–243PubMedGoogle Scholar
  33. Fowler J (2001) Is α/β for prostate tumors really low? Int J Radiat Oncol Biol Phys 50(4):1021–1031PubMedGoogle Scholar
  34. Fukumitsu N, Sugahara S, Nakayama H et al. (2009) A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 74(3):831–836PubMedGoogle Scholar
  35. Fuss M et al. (2000) Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 48(5):1381–1387PubMedGoogle Scholar
  36. Fuss M, Hug EB, Schaefer RA et al. (1999) Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and standard photon technique. Int J Radiat Oncol Biol Phys 45(5):1117–1126PubMedGoogle Scholar
  37. Garden AS, Weber RS, Morrison WH et al. (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32(3):619–626PubMedGoogle Scholar
  38. Glanzmann C (1990) Long-term results of postoperative and primary radiotherapy of carcinoma of the salivary glands: importance of dosage and target volume. Strahlenther Onkol 166(3):183–189PubMedGoogle Scholar
  39. Griffin BR, Laramore GE, Russell KJ et al. (1989) Fast neutron radiotherapy for advanced malignant salivary gland tumors. Radiother Oncol 12:105–111Google Scholar
  40. Gudjonsson O, Blomquist E, Nyberg G et al. (1999) Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 141:933–940Google Scholar
  41. Haberer T, Becher W, Schardt D et al. (1993) Magnetic scanning system for heavy ion therapy. Nucl Instr Meth Phys Res 330:296–305Google Scholar
  42. Habrand JL, Schneider R, Alapetite C, et al. (2008) Proton therapy in pediatric skull base and cervical cancal low-grade bone malignancies. Int J Radiat Oncol Biol Phys 71(3):672–675PubMedGoogle Scholar
  43. Hanks GE, Hanlon AL, Pinover WH et al. (2000) Dose escalation for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46(4):823–832PubMedGoogle Scholar
  44. Hata M, Tokuuye K, Kagei K et al. (2007) Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys 68(3):786–793PubMedGoogle Scholar
  45. Hof H, Muenter M, Oetzel D, et al.(2007) Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110(1):148–155PubMedGoogle Scholar
  46. Huber PE, Debus J, Latz D et al. (2001) Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 59:161–167PubMedGoogle Scholar
  47. Hug EB, Loredo LN, Slater JD et al. (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432–439PubMedGoogle Scholar
  48. Hug EB, Adams J, Fitzek M et al. (2000 a) Fractionated, threedimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 47(4):979–984PubMedGoogle Scholar
  49. Hug EB et al. (2000 b) Management of atypical and malignant meningiomas: role of high-dose 3D-conformal radiation therapy. J of Neuro-Oncology 48:151–160Google Scholar
  50. Hug EB, Münter MW, Archambeau JO et al. (2002 a) Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 178:10–17PubMedGoogle Scholar
  51. Hug EB, Sweeney RS, Nurre PM et al. (2002 b) Proton radiotherapy in the management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 52:1017–1024PubMedGoogle Scholar
  52. Igaki H, Tokuuye K, Okumura T et al. (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60(4):1120–1126PubMedGoogle Scholar
  53. Imada H, Kato H, Yasuda S, et al. (2010) Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol Jun 23, epub ahead of printGoogle Scholar
  54. Imai R, Kamada T, Tsuji H et al. (2004) Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 10:5741–5746PubMedGoogle Scholar
  55. Imai R, Kamada T, Tsuji H et al. (2009) Effect of carbon ion radiotherapy for sacral chordoma : results of phase I-II and Phase II clinical trials. Int J Radiat Oncol Biol Phys, in pressGoogle Scholar
  56. Kamada T, Tsujii H, Tsuji H et al. (2002) Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 15, 20(22):4466–4471PubMedGoogle Scholar
  57. Kato H, Tsujii H, Miyamato T et al. (2004) Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59(5):1468–1476PubMedGoogle Scholar
  58. Koto M, Miyamato T, Yamamoto N et al. (2004) Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 72(2):147–156Google Scholar
  59. Krämer M, Scholz M (2000) Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 45:3319–3330PubMedGoogle Scholar
  60. Krüll A, Schwarz R, Engenhart R et al. (1996) European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother 83 (Suppl):125–129Google Scholar
  61. Krüll A, Schwarz R, Brackrock S et al. (1998) Neutron therapy in malignant salivary gland tumors: results at European centers. Recent Results Cancer Res 150:88–99PubMedGoogle Scholar
  62. Laramore GE et al. (1993) Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 27(2):235–240PubMedGoogle Scholar
  63. Laramore GE, Krall JM, Thomas FJ et al. (1993) Fast neutron radiotherapy for locally advanced prostate cancer: final report of a Radiation Therapy Oncology Group randomized clinical trial. Am J Clin Oncol 16:164–167PubMedGoogle Scholar
  64. Levy RP et al. (1999) Stereotactic radiosurgery. The role of charged particles. Acta Oncologica 38(2):165–169PubMedGoogle Scholar
  65. Lin R, Hug EB, Schaefer RA et al. (2000) Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol Biol Phys 48:1219–1226PubMedGoogle Scholar
  66. Louis DN (2007). International Agency for Research on Cancer. WHO Classification of tumors of the central nervous system. Lyon: International Agency for Research on CancerGoogle Scholar
  67. Maire JP, Caudry M, Guerin J et al. (1995) Fractionated radiation therapy in the treatment of intracranial meningiomas: local control, functional efficacy and tolerance in 91 patients. Int J Radiat Oncol Biol Phys 33:315–321PubMedGoogle Scholar
  68. Milker-Zabel S, Debus J, Thilmann C et al. (2001) Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50(5):1279–1286PubMedGoogle Scholar
  69. Milosevic MF et al. (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34(4):817–822PubMedGoogle Scholar
  70. Miralbell R, Bleher A, Guguenin P et al. (1997) Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 37:523–529PubMedGoogle Scholar
  71. Miyamato T, Yamamoto N, Nishimura H et al. (2003) Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 66(2):127–140Google Scholar
  72. Miyamoto T, Baba M, Yamamoto N et al. (2007a) Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 67(3):750–758Google Scholar
  73. Miyamoto T, Baba M, Sugane T et al. (2007b) Carbon ion radiotherapy for stage I non-small-cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2(10):916–926Google Scholar
  74. Mizoe JE, Tsujii H, Kamada T et al. (2004) Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 60(2):358–364PubMedGoogle Scholar
  75. Mizoe JE, Tsujii H, Hasegawa A et al. (2007) Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas : combined x-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69(2):390–396PubMedGoogle Scholar
  76. Mizoe JE, Hasegawa A, Takagi R, et al. (2009) Carbon ion radiotherapy for skull base chordoma. Skull Base 19(3):219–224PubMedGoogle Scholar
  77. Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175 (Suppl II):57–63PubMedGoogle Scholar
  78. Munzenrider JE (1999) Proton therapy for uveal melanomas and other eye lesions. Strahlenther Onkol 175 (Suppl II):68–73PubMedGoogle Scholar
  79. Muthukumar N, Kondziolka D, Lunsford LD et al. (1998) Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 41:387–392PubMedGoogle Scholar
  80. Nihei K, Ogino T, Ishikura S, Nishimura H (2006) High-dose proton beam therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65(1):107–111PubMedGoogle Scholar
  81. Noel G, Habrand JL, Jauffret E et al. (2003) Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and pattern of failure. Strahlenther Onkol 179(4):241–248PubMedGoogle Scholar
  82. Noel G, Feuvret L, Ferraud R, et al. (2004) Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery 55(6):1252–1260PubMedGoogle Scholar
  83. Noel G, Habrand JL, Jauffret E, et al. (2005) Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and protons beams. Acta Oncologica 44:700–708PubMedGoogle Scholar
  84. Noel G, Bollet MA, Calugaru V et al. (2005) Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys 62(5):1412–1422PubMedGoogle Scholar
  85. Oelfke U, Bortfeld T (2001) Inverse planning for photon and proton beams. Med Dosim 26(2):113–124PubMedGoogle Scholar
  86. Pasquier D, Bijmolt S, Veninga T et al. (2008) Atypical and malignant meningioma : partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 71(5):1388–1393PubMedGoogle Scholar
  87. Pijls-Johannesma M, Grutters JP, Verhaegen F et al. (2010) Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist 15(1):93–103PubMedGoogle Scholar
  88. Pollack A, Zagars GK, Starkschall G et al. (2002) Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53(5):1097–1105PubMedGoogle Scholar
  89. Pötter R, Prott FJ, Micke O et al. (1999) Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. Strahlenther Onkol 175 (Suppl II):65–68Google Scholar
  90. Pommier P, Liebsch N, Deschler D et al. (2006) Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132:1242–1249PubMedGoogle Scholar
  91. Romero J, Cardenes H, la Torre A et al. (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32PubMedGoogle Scholar
  92. Rosenberg AE, Nielsen GP, Keel SB, et al. (1999) Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 23(11):1370–1378.PubMedGoogle Scholar
  93. Russell KJ, Kaplan RJ, Laramore GE et al. (1993) Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. Int J Radiat Oncol Biol Phys 28:47–54Google Scholar
  94. Sauerwein W et al. (1999) Strahlentherapie intraokulärer Tumoren. Onkologe 5:781–791Google Scholar
  95. Schneider U, Lomax A, Lombriser N (2000) Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin’s disease with photon and proton radiation. Radiat Res 154:382–388PubMedGoogle Scholar
  96. Schoenekaes KG, Prott FJ, Micke O et al. (1999) Radiotherapy on adult patients with soft tissue sarcoma with neutrons or photons. Anticancer Res 19(3B):2355–2359Google Scholar
  97. Scholz M, Kraft-Weyrather W, Ritter S et al. (1994) Cell cycle delays induced by heavy ion irradiation of synchronous mammalian cells. Int J Radiat Biol 66(1):59–75PubMedGoogle Scholar
  98. Scholz M, Kellerer AM, Kraft-Weyrather W et al. (1997) Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys 36:59–66PubMedGoogle Scholar
  99. Scholz M, Kraft G (1994) Calculation of heavy ion irradiation probabilities based on track structure, x-ray sensitivity and target size. Radiat Prot Dosim 52:29–33Google Scholar
  100. Schulz-Ertner D, Karger CP, Feuerhake A, et al. (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordoms. Int J Radiat Oncol Biol Phys 68(2), 449–457PubMedGoogle Scholar
  101. Schulz-Ertner D, Nikoghosyan A, Hof H, et al. (2007 b) Carbon ion radiotherapy in chondrosarcomas. Int J Radiat Oncol Biol Phys 67(1):171–177PubMedGoogle Scholar
  102. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. (2005) Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104:338–344PubMedGoogle Scholar
  103. Schwartz DL, Einck J, Bellon J et al. (2001) Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence. Int J Radiat Oncol Biol Phys 50(2):449–456PubMedGoogle Scholar
  104. Schwarz R, Krüll A, Lessel A et al. (1998) European Results of neutron therapy in soft tissue sarcomas. Rec Res Cancer Res 150:100–112Google Scholar
  105. Serizawa I, Kagei K, Kamada T et al. (2009) Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 75(4):1105–1110PubMedGoogle Scholar
  106. Shirato H, Shimizu S, Kunieda T et al. (2000) Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 48(4):1187–1195PubMedGoogle Scholar
  107. Slater JD, Rossi CJ Jr, Yonemoto LT et al. (2004) Proton therapy for prostate cancer: the initial Loma Linda University Experience. Int J Radiat Oncol Biol Phys 59(2):348–352PubMedGoogle Scholar
  108. Slater J, Yonemoto L, Mantik D et al. (2005) Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 62:494–500PubMedGoogle Scholar
  109. Steinberg GK et al. (1990) Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations. N Engl J Med 323(2):96–101PubMedGoogle Scholar
  110. Talcott JA, Rossi C, Shipley WU et at. (2010) Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA 303(11):1046–1053PubMedGoogle Scholar
  111. Thornton AF, Fitzek MM, Vavares M et al. (1998) Accelerated hyperfractionated proton/photon irradiation for advanced paranasal sinus cancer. Results of a prospective phase I-II study. Int J Radiat Oncol Biol Phys 42:222Google Scholar
  112. Tsuji H, Ishikawa H, Yanagi T et al. (2007) Carbon-ion radiotherapy for locally advanced or unfavourably located choroidal melanoma : a phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 67:857–862PubMedGoogle Scholar
  113. Tsujii H, Miyamato T, Mizoe J et al. (2002) Experience of carbon ion radiotherapy at NIRS. In: Kogelnik HD (ed) Progress in Radio-Oncology VII. Monduzzi Editore, Italy, pp 393–405Google Scholar
  114. Vikram B, Strong EW, Shah JP et al. (1984) Radiation therapy in adenoid cystic carcinoma. Int J Radiat Oncol Biol Phys 10(2):221–223PubMedGoogle Scholar
  115. Weber DC, Rutz HP, Bolsi A et al. (2007) Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience. Int J Radiat Oncol Biol Phys 69(3):865–871PubMedGoogle Scholar
  116. Wenkel E, Thornton AF, Finkelstein D et al. (2000) Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48(5):1363–1370PubMedGoogle Scholar
  117. Wulf J, Hädinger U, Oppitz U et al. (2001) Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177:645–655PubMedGoogle Scholar
  118. Yanagi T, Mizoe J, Hasegawa A et al. (2009) Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 74:15–20PubMedGoogle Scholar
  119. Yeboah C, Sandison GA (2002) Optimized treatment planning for prostate cancer comparing IMPT, VHEET and 15 MV IMXT. Phys Med Biol 47(13):2247–2261PubMedGoogle Scholar
  120. Zagars GK, Ballo MT (2003) Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 56(2):473–481PubMedGoogle Scholar
  121. Zelefsky MJ, Cowen D, Fuks Z et al. (1999) Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85(11):2460–2468PubMedGoogle Scholar
  122. Zelefsky MJ, Chan H, Hunt M et al. (2006) Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176(4):1415–1419PubMedGoogle Scholar
  123. Zietman AL, DeSilvio ML, Slater JD et al (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294(10):1233–1239PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • D. Schulz-Ertner
    • 1
  • J. Debus
    • 2
  1. 1.Abt. für Radioonkologie und StrahlentherapieMarkus KrankenhausFrankfurt am MainDeutschland
  2. 2.Abteilung für Radioonkologie und StrahlentherapieRadiologische KlinikHeidelbergDeutschland

Personalised recommendations